Replies to post #156943 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

QUOTE: We are extremely excited about Kevetrin’s prospects moving forward and feel we have a solid foundation upon which to proceed into advanced trials. To see disease stabilization in this Phase 1 trial with Kevetrin, as previously reported, let alone when optimal dosing has yet to be achieved, is exceptional, and only reinforces what we observed in our preclinical work conducted on animals. That Kevetrin showed clear signs of therapeutic response when it was only in a patient’s body for one day out of seven is encouraging. Additional lab work in animals is underway to better establish the mechanisms by which Kevetrin activates p53. We believe that establishing these data in the coming human trials will increase the demand for and value of Kevetrin many fold. We are also now exploring an oral formulation of Kevetrin, with the hope that Kevetrin can develop into a daily medicine for treating and defeating cancer.” - See more at: http://cellceutix.com/cellceutix-prepares-phase-2a-ovarian-cancer-trial-of-kevetrin-a-novel-p53-modulating-drug-candidate-based-upon-phase-1-topline-data/#sthash.pYJKvYuX.dpuf

[Golfguru03]

That was not a quote from Dr. Bertolino, it was from the author. To me, it was more a misunderstanding or as I said "a simplistic recap" of Kevetrin.